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Stephen W. Jamesa and Ralph P. Tatama
An optical ﬁbre long period grating (LPG) sensormodiﬁedwithmolecularly imprinted polymer nanoparticles
(nanoMIPs) for the speciﬁc detection of antibiotics is presented. The operation of the sensor is based on the
measurement of changes in refractive index induced by the interaction of nanoMIPs deposited onto the
cladding of the LPG with free vancomycin (VA). The binding of nanoMIPs to vancomycin was
characterised by a binding constant of 4.3  0.1  108 M. The lowest concentration of analyte
measured by the ﬁbre sensor was 10 nM. In addition, the sensor exhibited selectivity, as much smaller
responses were obtained for high concentrations (700 mM) of other commonly prescribed antibiotics
such as amoxicillin, bleomycin and gentamicin. In addition, the response of the sensor was characterised
in a complex matrix, porcine plasma, spiked with 10 mM of VA.1. Introduction
Fibre optic devices coated with functional nanomaterials that
exhibit changes in optical properties upon exposure to targeted
chemical species have emerged as a promising platform for the
development of bio and chemical sensors.1,2 The characteristics
of such sensors, such as sensitivity, selectivity and response/
recovery time, depend strongly upon the performance capabil-
ities and properties of the functional layer. Research in the eld
of bre optic chemical sensors has focused recently on the
development of new functional coatings. The functional mate-
rials should be transparent in the appropriate spectral range,
change their optical properties under the inuence of the
specic chemical species, have fast, ideally reversible response
with a wide dynamic range, be readily immobilized onto glass/
quartz/plastic bre, and be cheap to manufacture. In this
regard, molecularly imprinted polymers (MIPs) provide a
universal platform for the creation of articial receptors that
can be well controlled and tailored. Molecular imprinting is one
of the most promising approaches for achieving specic
molecular recognition. The technique is versatile, as any
compound with functional groups can, in principle, be
imprinted in diﬀerent porogens (either water or organic
solvents). The basic concept of molecular imprinting is based
on the creation of imprints of the template compoundool of Engineering, Craneld University,
ail: s.korposh@craneld.ac.uk
neld, Bedfordshire, MK43 0AL, UK
tion (ESI) available. See DOI:
hemistry 2014(i.e. chemical molecules or biological species that needs to be
detected – analytes) in a polymeric matrix, achieved by its
incorporation during the polymerization step. Molecular
imprinting is achieved in three steps, the rst being the
complex formation of the template with selected functional
monomers, followed by a polymerization step for creation of a
matrix that xes the monomers in the right position to interact
with the analyte and with the nal step being the removal of the
template to leave behind cavities specic for the template,
Scheme 1.
Although MIPs have already being identied as stable and
low cost mimics of receptors or enzymes for sensing applica-
tions,4–7 they are also perceived to have several shortcomings.
Among these are the heterogeneous distributions of binding
sites, which can produce high levels of non-specic binding and
have complex protocols for integration with sensors, which can
aﬀect the reproducibility and hence increase the variability
betweenmeasurements. Some of these issues can be resolved by
the use of MIP nanoparticles (nanoMIPs) in standard protocols
developed for the immobilisation of antibodies. The particles
used here were produced by a solid-phase synthesis approach
using a computer-controlled reactor. Such MIP nanoparticles
have been shown to have pseudo-monoclonal binding proper-
ties, uniform binding sites and high aﬃnity for the target used
as the template.8,9 Recently, such MIP nanoparticles were used
for the detection of vancomycin in a novel assay based on direct
replacement of antibodies.10 The assay was capable of
measuring vancomycin in buﬀer and in blood plasma within
the range of 0.001–70 nM with a detection limit of 0.0025 nM
(2.5 pM).Analyst, 2014, 139, 2229–2236 | 2229
Scheme 1 Schematic illustration of the molecular imprinting procedure.3
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View Article OnlineIn this work, nanoparticles produced following the protocol
described in ref. 10 were deposited onto an optical bre long
period grating (LPG) with the aim of developing a low cost,
highly sensitive and selective vancomycin sensor. Vancomycin is
a glycopeptide antibiotic derived from Amycolatopsis orientalis.11
The mode of action of vancomycin consists of the inhibition of
cell wall biosynthesis and alteration of the permeability of the
bacterial cell membrane. Vancomycin has been used to treat
various serious gram-positive infections. It is a powerful antibi-
otic, which in high doses can be toxic to the ears and kidneys,
whilst at low doses can cause hypersensitivity reactions. Thus it
is important to measure accurately the concentration of vanco-
mycin in blood to control its administration to patients. The
recommended therapeutic concentration range of vancomycin
in plasma is 15–20 mg L1.12 Immunoenzymatic techniques (e.g.
uorescence polarisation immunoassay (FPIA)(TDx), enzyme
multiplied immunoassay technique (EMIT), radioimmunoassay
(RIA), turbidimetric assays) and chromatographic methods are
the most commonly used in clinical environments for the
detection of vancomycin in plasma.13 The former, although
widely used because of their simplicity and speed, lacks preci-
sion, especially for the highest concentrations of the antibi-
otic.14,15 The latter can be very precise, but the techniques are
time consuming and require expensive instruments and highly
skilled operators. Therefore there is a need to develop reliable,
fast, cheap and easy to use sensors for clinical measurements of
vancomycin and antibiotics in general.
Regarding the sensor platform, a long period grating (LPG) is
a periodic modulation of the refractive index (RI) of the core of
an optical bre that results in the coupling of light between core
and cladding modes. Its combination with nanomaterials
provides a prospect for the fabrication of high sensitivity
sensors oﬀering specic binding to targeted chemical
species.16,17 Recently, we have demonstrated the use of optical
bre LPG sensors modied with diﬀerent functional coatings
for the detection of ammonia18 and aromatic carboxylic acids.19
The coupling between core and cladding modes occurs when
the phase matching condition is satised:lx ¼ (ncore  nclad(x))L (1)
where lx represents the wavelength at which light is coupled to
the LP0x cladding mode, ncore is the eﬀective refractive index of
the mode propagating in the core of the bre, nclad(x) is the2230 | Analyst, 2014, 139, 2229–2236eﬀective index of the LP0x cladding mode and L is the period of
the LPG.
The transmission spectrum of an optical bre containing an
LPG is characterised by a series of resonance bands centred at
the wavelengths satisfying eqn (1). The dependences of the
cladding modes eﬀective refractive indices on the surrounding
refractive index are manifested as changes in the central
wavelengths of the resonance bands, which has been exploited
as a refractive index sensor and non-specic concentration
sensor,20 and by, coating with the cladding of the optical bre in
the section containing the LPG with a functional material,
chemical sensors in both the liquid and gas phases.17,18
The combination of optical bre based sensing platforms
with MIPs has already been attempted by several research
groups. Previous reports have exploited surface plasmon reso-
nance on metal coated optical bres21,22 or have used a uo-
rescence signal,23 rather than LPGs. In all of these examples the
MIP layer was produced in situ on the bre, making large scale
production of the optical sensors more challenging because of
the need to control polymerization conditions to achieve high
quality and reproducible MIP layers. In this paper, the MIP layer
was deposited onto the optical bre by simply immersing the
optical bre into a solution of soluble and easy-to-manipulate
MIP nanoparticles. The nanoMIPs-modied optical bre LPG
was used to measure vancomycin in a concentration range from
10 nM to 700 mM, equivalent to 14 mg L1 and 1 g L1, respec-
tively. The lower concentration was chosen with the intention of
assessing if this sensor was capable of measurements in
dilutions of real samples, which would be helpful to reduce
interferences when testing biological samples like plasma. The
mid-range includes the recommended therapeutic concentration
range, while the higher concentration was investigated to assess
the concentrations at which the sensor response saturates. The
selectivity of the sensor was tested against other commonly
prescribed antibiotics such as gentamicin, amoxicillin and
bleomycin.24 In addition, to check the sensor performance in a
complex biological matrix, the response to vancomycin was also
measured in porcine plasma spiked with the antibiotic.2. Experimental section
2.1 Materials
N-Isopropylacrylamide (NIPAm), acrylic acid (AA), N,N0-methy-
lene-bis-acrylamide (BIS), N-tert-butylacrylamide (TBAm),This journal is © The Royal Society of Chemistry 2014
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View Article Onlineammonium persulfate (APS), tetramethylethylenediamine
(TEMED), 3-aminopropyltrimethyloxysilane (APTMS), glutaral-
dehyde (GA), ethanolamine, phosphate buﬀered saline (PBS),
methanol, ethanol, toluene and acetone were purchased from
Sigma-Aldrich, UK. The antibiotics vancomycin (VA), amoxi-
cillin, bleomycin sulphate salt, gentamicin sulphate salt
(Scheme 2) were also from Sigma-Aldrich. N-(3-Aminopropyl)
methacrylamide hydrochloride (APMA) was from Polysciences
Europe GmbH, Germany. All the chemicals were of analytical
grade, and used without further purication. Double-distilled
ultrapure water (Millipore, UK) was used for the experiments.
Phosphate buﬀered saline (PBS) was prepared as directed from
PBS buﬀer tablets (Sigma-Aldrich, Gillingham, UK) and
comprised phosphate buﬀer (0.01 M), potassium chloride
(0.0027 M) and sodium chloride (0.137 M), pH 7.4, at 25 C.
Where PBS, pH 7.2, was used, the pH was adjusted by the
addition of HCl.2.2 Synthesis of MIP nanoparticles (nanoMIPs) imprinted
with vancomycin
The protocol for the immobilization of vancomycin on solid
supports (glass beads) has been described elsewhere.8 An
automated reactor, upgraded compared to that used previ-
ously,8 was utilized for the synthesis of the nanoparticles.
During the entire synthesis the template remains attached to
the glass beads. Once the high aﬃnity nanoparticles, formed
around the template, are collected with hot washing, the
template still remains attached to the solid surface and the
nanoparticles collected are already ‘template free’. This is one of
the major advantages of the solid support approach inScheme 2 Schematic illustration of the chemicals used for detection and
(d) gentamicin.
This journal is © The Royal Society of Chemistry 2014comparison with other methods used for the synthesis of
nanoparticles. Regarding the details of the automated
synthesis, the reactor, manufactured by HEL Ltd., (Boreham-
wood, UK), was designed to allow both photochemically- and
chemically-initiated polymerizations. All processes were
controlled with a computer, withminimal intervention from the
operator. For the preparation of nanoMIPs specic for vanco-
mycin, the polymerization mixture, which was adapted from
that published by Hoshino and colleagues25 consisted of NIPAm
(39 mg), BIS (2 mg), TBAm (33 mg dissolved in 2 mL of ethanol),
APMA (1.15 mg) and AA (2.23 g). The mixture was dissolved in
double-distilled water (100 mL), sonicated for 10 minutes and
degassed by bubbling with nitrogen for 30 minutes. For the
automated synthesis of nanoMIPs, glass beads functionalized
with vancomycin (60 g) were added to the reaction cylinder.
Using a syringe pump, an aliquot of the polymerization mixture
(60 mL) was added directly into the cylinder and then stirred
briey to homogenize the contents. Polymerization was initi-
ated by the addition of a solution of APS (60 mg mL1, 600 mL)
and TEMED (18 mL) followed by stirring. The monomer mixture
was le to polymerize at ambient temperature for 1.5 hours and
a brief stirring (30 s at 600 rpm) was applied at the end of each
30 min period. At the end, the polymerization mixture was
drained from the reaction vessel using a combination of suction
and nitrogen purging. Subsequently, washings were performed
at ambient temperature by adding water (2 aliquots of 50 mL) to
the cylinder. The contents were stirred and the washings, con-
taining unreacted monomers and other low aﬃnity materials,
removed and discarded. Next, a further 3 aliquots of water
(50 mL each) were individually added to the cylinder and the
temperature was raised to 60 C. At this temperature pureselectivity tests: (a) vancomycin (VA); (b) amoxicillin; (c) bleomycin and
Analyst, 2014, 139, 2229–2236 | 2231
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View Article Onlinefractions of nanoparticles were collected. The entire process
took approximately 3.5 hours. The stages of the synthesis were
pre-programmed into the WinISO® soware such that, once
started, the synthesis could be le to run without the necessity
for user supervision. The solution of nanoMIPs was concen-
trated to a nal volume of 100 mL by ultraltration on a Milli-
pore Amicon Ultra centrifugal lter unit (30 kDa MWCO) and its
concentration (0.2 mg mL1) determined by weighing a freeze-
dried aliquot. The size of the nanoparticles measured by
dynamic light scattering (DLS) using a Zetasizer Nano (Nano-S)
from Malvern Instruments Ltd (Malvern, UK) was around
280 nm. Prior to DLS measurements, performed at 25 C, the
solution of nanoMIPs was subjected to sonication for 5 minutes.2.3 Sensor fabrication and functionalization
An LPG with a length of 30 mm and a period of 111 mm was
fabricated in boron–germanium co-doped single mode optical
bre (Fibercore PS750) with a cut-oﬀ wavelength of 670 nm, in a
point-by-point fashion, side-illuminating the optical bre by the
output from a frequency-quadrupled Nd:YAG laser, operating at
266 nm. The period of the LPG was chosen to ensure operation
at the phase matching turning point, a condition known to oﬀer
the highest sensitivity.26 The bre was xed tightly in a Teon
cell as described previously.15–18 For transmission spectra (TS)
measurements, one proximal end of the bre was connected to
a spectrometer (S200, Ocean Optics) and the distal end to a
tungsten halogen lamp (HL-2000, Ocean Optics).
Prior to the deposition of the nanoMIPs, the region of the
optical bre containing the LPGs was rinsed with double-
distilled water and immersed into 1 wt% ethanolic KOH
(ethanol–water ¼ 3 : 2, v/v) for 20 min, leading to formation of
hydroxyl groups on the bre surface. The bre was then
immersed into a 2% v/v solution of APTMS in dry toluene forScheme 3 Schematic illustration of the protocol used to immobilize na
2232 | Analyst, 2014, 139, 2229–2236diﬀerent time intervals to nd the optimal conditions, washed
with acetone and subsequently incubated in a 1% v/v solution of
GA in PBS (pH 7.2) for 1 hour. The LPG bre was then rinsed
with double-distilled water and immersed into a nanoMIPs
solution (0.2 mg mL1) for 2 h. Aer rinsing with double-
distilled water, the bre was immersed for 30 minutes into an
ethanolamine water solution (0.1 M), to block the remaining
free carbonyl groups of GA, and following a nal wash with
double-distilled water, the sensor was ready to be used. A
schematic representation of the nanoMIPs immobilization
protocol is reported on Scheme 3. The transmission spectrum
(TS) of the LPG was measured aer each step of the surface
treatment.2.4 Sensitivity and selectivity tests
Aer the functionalization, the sensor was exposed to variable
concentrations of VA by immersion into 600 mL solution for 45
min, as aer this time there was no change in measured signal.
This was followed by thorough rinsing with distilled water and
drying by purging with dry nitrogen to remove any physically
adsorbed compounds. The transmission spectrum (TS) of the
LPG was measured aer each exposure to analyte and inter-
fering substances. To avoid issues with sensitivity of the LPG to
the bulk refractive index, all TS measurements were conducted
in air. In order to take into account the potential diﬀerence in
the light source intensity between diﬀerent measurements the
TS were normalised by taking an automatic baseline for each
measured TS using Origin 7.5 soware. Aer each exposure, a
solution of NaOH (0.1 M) was used to regenerate the sensor by
removing the VA adsorbed to the nanoMIPs. The sensor selec-
tivity was tested by exposure to other common antibiotics
(amoxicillin, gentamicin and bleomycin) with a concentration
of 600–700 mM. The nanoMIPs-modied LPG was alsonoMIPs.
This journal is © The Royal Society of Chemistry 2014
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View Article Onlineimmersed into porcine plasma spiked with 10 mM of vanco-
mycin to check the sensor performance in a complex biological
matrix.
It should be noted that the eﬀect of the non-imprinted
nanoparticles was thoroughly studied in the previous work with
ELISA assay10 where the imprinting eﬀect of the nanoMIPs was
clearly demonstrated and was not included in this current study.Fig. 2 (a) Evolution of the TS of the APTMS-coated optical ﬁbre LPG
during the deposition of 1 wt% GA, measured in solution at diﬀerent
interval times: black line, before GA deposition; red line, 15 min; and
green line, 1 h after GA deposition; (b) TS measured in air: black line,
before GA deposition, and red line, after GA deposition.3. Results and discussion
3.1 NanoMIPs deposition
The rst step to immobilize covalently nanoMIPs onto the
optical bre involved the deposition of a thin silane lm onto
the hydroxyl groups on the bre surface formed by the KOH
ethanolic solution. To do this the bre was immersed into 2% v/
v solution of APTMS in dry toluene. The silane also provides the
surface with the primary amino groups necessary for
the subsequent immobilization steps. Fig. 1 shows the TS of the
LPG with grating period of 111 mm, measured in air before and
aer 1 hour deposition of the APTMS. It should be noted that, in
order to take into account the potential diﬀerence in the
intensity of the light source between diﬀerent measurements
(Fig. S1†), the TS were normalised by taking an automatic
baseline for each measured TS using Origin 7.5 soware. The
blue shi of the linearly polarised (LP) mode LP018 resonance,
along with the appearance of the dual resonance for the LP019
mode resonance, is characteristic of the response of the LPG to
the deposition of a thin lm onto the cladding of the bre.
Following the deposition of the silane, the bre was
immersed into a PBS solution of GA, Fig. 2a and b. Similarly to
that observed following the deposition of the APTMS lm, a
further blue shi of the LP018 resonance, and further develop-
ment of the LP019 dual resonance bands were observed,
demonstrating a successful deposition of GA via attachment of
the carbonyl groups of GA to the amino groups of the silane.
When measured in solution, the LP019 resonance band exhibi-
ted a signicant wavelength shi during the rst 15 min from
the start of the GA deposition, with the response saturating at
around 30 min, as shown in Fig. 2a. Fig. 2b shows the TS
measured in air before and aer GA deposition, with theFig. 1 TS of the LPG measured in air: black line, before APTMS
deposition, and red line, after APTMS deposition.
This journal is © The Royal Society of Chemistry 2014changes in the spectra indicating an increase of the optical
thickness of the lm.
Aer GA deposition, the LPG was immersed into a water
solution of nanoMIPs (0.2 mg mL1) for 2 hours, Fig. S2.† The
amino groups contained in the nanoMIPs (due to the monomer
APMA) create a bond with the carbonyl groups of GA. The minor
change in the LP018 resonance band apparent aer the immo-
bilization of nanoMIPs can be explained by successful attach-
ment of the nanoparticles to the GA surface. The nal step of
the MIP sensor fabrication was the blocking by ethanolamine
(0.1 M) of any available carbonyl groups remaining on GA,
Fig. S3.† A small change in the TS was observed, revealing the
adsorption of the ethanolamine.
3.2 Vancomycin detection
Aer the immobilization of the nanoMIPs and blocking with
ethanolamine, the LPG was exposed to increasingAnalyst, 2014, 139, 2229–2236 | 2233
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View Article Onlineconcentrations of VA solution. Each concentration was incu-
bated for 45 minutes (Fig. 3a) as, aer this time, the single was
saturated, Fig. S4.† It should be noted, however, that these data
cannot be directly used to assess amount that was bound, as the
refractive index of the solution plays some role in the sensor
response. The LPG was washed with 0.1 M NaOH aer each
exposure (Fig. S5†). As the concentration of VA increased, the
change in the TS becomes more pronounced, indicating an
increase in the amount of VA bound to the nanoMIPs. This
behaviour of the TS of the coated LPG bre is typical of that
observed when the RI of the sensitive layer increases.15–18 The
resonance band at ca. 670 nm, which is coupled to the linearly
polarized 18th cladding mode (LP018), exhibits blue shis of
0.22, 0.40, 0.60 and 0.88 nm for the 0.01, 0.1, 10 and 700 mM VA
concentrations, respectively. The transmission intensity of the
resonance band at ca. 833 nm, corresponding to coupling to the
LP019 modes, decreases for 2.85, 4.93, 11.96 and 15.63% for
0.01, 0.1, 10 and 700 mMVA concentrations, respectively, Fig. 3a.
The sensor response starts to saturate at a concentration of VA
of 700 mM, indicating the specic nature of VA binding, Fig. 3b.Fig. 3 (a) TS of the nanoMIP coated LPG measured in air after expo-
sure to VA concentrations ranging from 10 nM to 700 mM. (b)
Dependence of the transmission at the centre of the resonance band
corresponding to coupling to the LP019 mode (square) and wavelength
shift of the resonance band corresponding to coupling to the LP018
mode (circle) on the concentration of VA. The red and black lines are
ﬁts using the Langmuir adsorption isotherm. The inset shows the
logarithmic dependence of transmission at the centre of the reso-
nance band corresponding to coupling to the LP019 mode on VA
concentration.
2234 | Analyst, 2014, 139, 2229–2236The main focus of the sensor characterisation was on concen-
trations lower than the physiological range (10 nM), demon-
strating that this approach could be used to develop a sensor
with sensitivity that would need dilutions of real samples before
testing. This approach would have the eﬀect of reducing inter-
ferences when testing biological samples like plasma.
When the nanoMIP-modied LPG was regenerated with
NaOH (0.1 M) the signal returned to its original value, indi-
cating total removal of VA from the nanoMIPs, Fig. S5.† The
binding of VA to the nanoMIPs was tted with a Langmuir
model using the standard package available in Origin soware
(Fig. 3b and S6†). The binding constant of VA to the nanoMIPs
lm, calculated using a Scatchard–Rosenthal plot in accordance
with the eqn (2) (Fig. S5†), was 4.3  0.01  108 M.27
Bmax
B
¼ Kd 1
c
þ 1; (2)
where Bmax is the maximum amount of VA bound (sensor
response at highest concentration), B is the amount of VA
bound at a given concentration (sensor response at a given
concentration), Kd is the binding constant and c is the
concentration of VA.
The standard deviation, s, obtained from 5 exposures to
blank sample (Fig. S6†) and 10 mM of VA, was 0.24% and
0.12 nm for the transmission and wavelength measurements,
respectively. For transmission measurements, the limit of
detection of the sensor system was found to be 1.8 nM, deter-
mined by calculating the 3s value.27
Fig. 4 shows the TSmeasured in air before and aer exposure
(for 45minutes) to porcine plasma with and without VA (10 mM).
A small sensor response was observed for plasma without VA.
The response increased when 10 mM of VA was present in the
plasma, Fig. 4. These results suggest that the sensor can reliably
perform VA detection in a complex medium such as plasma. It
should be noted, however, that response to 10 mM of VA was
larger when measured in plasma as compared to VA in PBS. The
most plausible explanation for this is the eﬀect of the complex
medium on the sensor response; this phenomenon could beFig. 4 TS of the nanoMIP coated LPG, measured in air before (black
line) and after exposure to, porcine plasma (red line) and porcine
plasma spiked with 10 mM of VA (green line).
This journal is © The Royal Society of Chemistry 2014
Fig. 5 TS of the nanoMIP-coated LPG, measured in air after exposure
to, VA (670 mM) (red line), amoxicillin (690 mM) (green line); bleomycin
(706 mM) (blue line) and gentamicin (690 mM) (magenta line).
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View Article Onlinesolved either by further optimisation of the blocking of the
particles or by performing an antibiotic calibration curve
directly in plasma which should negate the eﬀect of the complex
medium. This will be studied in more detail in future work.
3.3 Selectivity test
When the nanoMIPs-modied LPG was exposed to solutions of
amoxicillin (610 mM), bleomycin (700 mM) and gentamicin
(660 mM), each prepared in PBS, no measurable changes in the
central wavelength of the resonance band corresponding to
coupling to the LP018mode, nor of the transmission at the centre
of the resonance band corresponding to coupling to the LP019
mode were observed, revealing the high selectivity of the LPG
sensor towards other commonly prescribed antibiotics, (Fig. 5).
4. Conclusions
In conclusion, molecularly imprinted polymer nanoparticles
specic for VA were successfully deposited for the rst time onto
an optical bre long period grating. The sensor demonstrated
high sensitivity (10 nM with 4.3  0.01  108 M1 binding
constant) to VA and selectivity over other antibiotics such as
amoxicillin, bleomycin and gentamicin. Successful detection of
VA in a complex biological matrix, porcine plasma was also
demonstrated. The LPG sensor based on molecular imprinted
nanoparticles presented here is a promising tool for detection
of antibiotics in biological uids. In addition, the generic
nature of both the LPG sensor and the nanoMIP prepared by
solid-phase synthesis suggests that by immobilizing diﬀerent
nanoMIPs (produced against a diﬀerent analyte), low cost and
easy to use optical bre sensors can be produced for applica-
tions in a variety of elds, from medical and environmental to
food and industry.
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